# FDA Inspection 1262721 - Cleveland Clinic - February 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/cleveland-clinic/3cc94031-9b72-4040-ad68-6cfb9fdfc6b2
Source feed: FDA_Inspections

> FDA Inspection 1262721 for Cleveland Clinic on February 26, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262721
- Company Name: Cleveland Clinic
- Inspection Date: 2025-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262721 - 2025-02-26](https://www.keypedia.com/records/fda_inspections/cleveland-clinic/13e70585-dd4f-4446-832e-984cbb3b85a9)
- [FDA Inspection 1253266 - 2024-10-28](https://www.keypedia.com/records/fda_inspections/cleveland-clinic/4240c665-c88c-43a9-8017-5cc7c1652dee)
- [FDA Inspection 1177574 - 2022-07-18](https://www.keypedia.com/records/fda_inspections/cleveland-clinic/e1c7d269-713f-42c6-9cb5-d60a66943ac8)
- [FDA Inspection 1177574 - 2022-07-18](https://www.keypedia.com/records/fda_inspections/cleveland-clinic/5343b533-16cf-40f5-a033-7ab3646ab684)
- [FDA Inspection 1099199 - 2019-07-17](https://www.keypedia.com/records/fda_inspections/cleveland-clinic/90f5dd65-dd20-49e1-875c-a4313e69fb35)

Company: https://www.keypedia.com/companies/cleveland-clinic/ddd7681b-3281-44b9-9e25-3276e117091b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d